Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Daniel Bentley

Physician Assistant, Surgical Rockford, IL Physician Assistant

NPI 1629177647 CMS profile 10723511

1401 E State St, Rockford, IL 61104

Open in the dashboard

General payments

$6,779

74 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Bentley of Rockford, IL is reported in the CMS Open Payments database as having received $6,779 across 74 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,097 21
2024 General $2,752 25
2023 General $610 7
2022 General $321 4
2021 General $1,000 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Bentley
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Daniel Bentley were reported at $2,097. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Daniel Bentley Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,000 $111 $36–$285 $132
2022 $321 $126 $44–$350 $149
2023 $610 $137 $47–$355 $160
2024 $2,752 $146 $49–$384 $164
2025 $2,097 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Atricure, Inc. $2,110 24 payments
  2. CVRx, Inc. $1,264 8 payments
  3. Medical Device Business Services, Inc. $1,030 6 payments
  4. Edwards Lifesciences Corporation $526 9 payments
  5. Maquet Cardiovascular U.S. Sales, L.L.C. $508 7 payments
  6. Saphena Medical, Inc. $295 3 payments
  7. Abiomed $271 3 payments
  8. Davol Inc. $143 2 payments
  9. Chiesi USA, Inc. $116 1 payment
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $113 1 payment
  11. Other $404 10 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,626 66 payments
  2. Travel and Lodging $2,153 8 payments
Products named General payments · program years 2021–2025
  1. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $1,280 13 payments
  2. Barostim Neo System $1,264 8 payments
  3. SYNERGY ABLATION SYSTEM $801 6 payments
  4. AtriCure cryoICE cryoSPHERE Cryoablation System $630 7 payments
  5. Venapax $295 3 payments
  6. Vasoview Hemopro 2 Cardiology/Vascular Diseases $290 5 payments
  7. INSPIRIS RESILIA AORTIC VALVE $260 4 payments
  8. CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS $253 4 payments
  9. ATRICLIP LAA EXCLUSION SYSTEM $152 4 payments
  10. VASOVIEW HEMOPRO 2 Cardiovascular Care $139 1 payment
  11. Other $1,014 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

36

Median for Physician Assistant: 241

Drug cost

$197

Median for Physician Assistant: $4,110

Branded share of claims

63.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $151
Tramadol Hcl Generic 13 $46

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Records

74 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record